Dow and broader stock-market futures turn positive amid upbeat report on Gilead's experimental coronavirus treatment - MarketWatch

Dow and broader stock-market futures turn positive amid upbeat report on Gilead’s experimental coronavirus treatment – MarketWatch

U.S. stock-index futures turned positive on Friday after a report from Gilead Sciences indicated that its experimental treatment for coronavirus was seeing positive results in reducing deaths. Futures for the Dow Jones Industrial Average YM00, +0.48% YMU20, +0.48% were up 0.1% at 25,600, those for the S&P 500 index ES00, +0.22% ESU20, +0.22% were trading up 0.1% at 3,144, while Nasdaq-100 futures NQ00, -0.06% NQU20, -0.06% advanced 0.1% at 10,740. Gilead published a report on Friday saying that its antiviral drug remdesivir showed that it reduced the risk of death for coronavirus patients by 62% compared with standard care alone. The findings are being presented at the Virtual Covid-19 Conference as part of the 23rd International AIDS Conference, the company said.

Credit: Source

Leave A Comment

Your email address will not be published. Required fields are marked *